SCHA vs XLV
Schwab US Small-Cap ETF vs Health Care Select Sector SPDR Fund
- • SCHA has the lower expense ratio at 0.03% vs 0.08% for XLV.
- • XLV pays a higher dividend yield (1.38%).
Side-by-side metrics
| Metric | SCHA | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.03% | 0.08% |
Dividend yield Trailing 12-month yield. | 1.12% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $22.04B | $49.10B |
YTD return | 18.09% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 1.23 | 0.41 |
P/E ratio | 16.37 | 30.63 |
Last price | $33.55 | $187.94 |
Inception | — | — |
Issuer | Schwab | State Street |
SCHA top holdings
| HALO | Halozyme Therapeutics Inc | 0.36% |
| GKOS | Glaukos Corp | 0.34% |
| W | Wayfair Inc Class A | 0.32% |
| BMNR | BitMine Immersion Technologies Inc | 0.29% |
| AHR | American Healthcare REIT Inc Ordinary Shares | 0.28% |
| BTSG | BrightSpring Health Services Inc | 0.27% |
| R | Ryder System Inc | 0.26% |
| VSAT | Viasat Inc | 0.26% |
| ENSG | Ensign Group Inc | 0.25% |
| WTFC | Wintrust Financial Corp | 0.25% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About SCHA
SCHA (Schwab US Small-Cap ETF) is US small-cap equities. Managed by Schwab, the fund carries $22.0B in assets under management, an expense ratio of 0.03%, a dividend yield of 1.12%. Its largest holding is Halozyme Therapeutics Inc (HALO), which represents 0.4% of the portfolio. Real Estate is the fund's largest sector exposure at 6.9%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.